Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Influenza, Human 4Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Patient Acceptance of Health Care 1Lymphoma, Non-Hodgkin 1Leukemia 1Infections 1Hematologic Neoplasms 1Healthy, no Evidence of Disease 1Health Behavior 1Colorectal Neoplasms 1COVID-19 1

Interventions

Standard of Care 9Exercise 9Educational Status 8Practice Guidelines as Topic 7Methods 7Blood Specimen Collection 7Early Intervention, Educational 6Palliative Care 5Interviews as Topic 5Behavior Therapy 5fludarabine 4Surveys and Questionnaires 4Physical Therapy Modalities 4Cyclophosphamide 4Magnetic Resonance Spectroscopy 3Health Promotion 3Granulocyte Colony-Stimulating Factor 3pegylated granulocyte colony-stimulating factor 2fludarabine phosphate 2Whole-Body Irradiation 2Therapeutic Touch 2Stem Cell Transplantation 2Restraint, Physical 2Radiosurgery 2Patient Navigation 2Parenteral Nutrition 2Low-Level Light Therapy 2Etoposide 2Cytarabine 2Control Groups 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematologic Neoplasms × Influenza Vaccines × Clear all
NCT01215981 2017-12-28

Influenza Vaccine Post Allogeneic Transplant

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
68 enrolled 6 charts
Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡